Ikarian Capital, LLC

SEC CIK: 0001778253
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

EPRX holding history

Eupraxia Pharmaceuticals Inc. in every 13F filed by Ikarian Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

EPRX overview All 13F holders of EPRX Full Q2 2026 holdings

Shares (Q2 2026): 809,741
Value: $5.35M
% of portfolio: 0.9%
Quarters held: 3; Since Q4 2025

Holdings of EPRX by Ikarian Capital, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	809,741	$5.35M	0.9%	−405,000−33.3%	Reduced	Holders
Q1 2026	1,214,741	$8.79M	1.3%	+604,741+99.1%	Added	Holders
Q4 2025	610,000	$4.61M	0.6%	+610,000	New	Holders